
Hikma obtains FDA OK for Tyzavan
Hikma has obtained permission from the Food and Drug Administration for a novel formulation of the first-of-its-kind, ready-to-infuse formulation of vancomycin, under the brand name Tyzavan (vancomycin injection). Tyzavan is a glycopeptide antibacterial …